The RAS/RAF/MEK/ERK and PI3K/AKT/mTOR cascades represent key signaling routes whose dysregulation contributes to tumor growth, survival, and therapeutic resistance in tumors harboring alterations such as KRAS, BRAF, PIK3CA, or PTEN. This evidence concerns the gene PIK3CA and neoplasm.